Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 77.00
+1.00 (1.32%)
Mar 25, 2026, 4:28 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.27 billion as of March 25, 2026. Its market cap has decreased by -35.71% in one year.
Market Cap
1.27B
Enterprise Value
1.24B
Revenue
250.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
77.00
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has decreased from 1.35B to 1.27B, a decrease of -6.31%. That is a compound annual growth rate of -1.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 1.27B | -33.41% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 124.44B |
| Getinge AB | 49.58B |
| Sectra AB | 42.43B |
| Medicover AB | 27.78B |
| Surgical Science Sweden AB | 1.56B |
| Carasent AB | 1.55B |
| EQL Pharma AB | 1.55B |
| BioInvent International AB | 1.46B |